Executive Interviews
Solving Myopia: From the Playground to the Global Stage
For John Nguyen, the moment of clarity did not happen behind a phoropter in a darkened consulting room. It happened at home, watching the daily struggle between screen time and sunshine that defines modern parenting. As an optometrist and founder of Luxi Health, Nguyen knows the clinical data well. He understands that the world is […]
The “Screen Time” Pandemic: Why the World’s Eyeballs are Getting Too Long
With nearly half the world projected to be myopic by 2050, Eyerising International is pioneering a “disease-modifying” solution using low-level red light therapy. The Australian MedTech firm is currently raising $5 million to fund its global expansion and entry into the massive adult treatment market.
Forget antibiotics: Why the next big medical breakthrough is a beam of light
Lindo Life Science, founded by Robert Gangi, is changing the battle against antimicrobial resistance (AMR) with the Lindo Tube, which uses occupant-safe antimicrobial blue light to shatter 99.9% of bacteria. This breakthrough prevents Ventilator-Associated Pneumonia (VAP), a secondary infection affecting nearly one in four intubated patients, and has been validated by a collaboration with the Mayo Clinic.
Why the Future of Heart Health is ‘Cuffless’
After 25 years in the Emergency Room, Dr. Joe is pioneering a new era in heart health with Zaplutus Health’s Ora Connect, a revolutionary ‘peel-and-stick’ wearable providing hospital-grade, continuous, cuff-less blood pressure data to transform patient care both inside and outside the hospital.
The GPS for Oncology: Ending the era of ‘blind’ cancer removal
Ferronova is pioneering the “GPS for Oncology” with magnetic nanoparticles, creating a high-definition roadmap to precisely trace cancer in lymph nodes and eliminate the guesswork of traditional surgery, a move from “search and destroy” to “trace and target.”
Forging a $100M Future: Why Prime Financial Puts People First in its Acquisition Strategy
ASX-listed Prime Financial Group is on an ambitious path to a $100 million revenue target. Chairman Simon Madder reveals their playbook isn’t just about capital; it’s about a founder-focused acquisition strategy where cultural fit is the ultimate litmus test. Discover how their unique partnership model, which includes offering significant equity to incoming founders, is fuelling one of the sector’s most compelling growth stories.
Australia’s Trillion-Dollar Defence Tech Boom: A Call to Action for Founders
The global defence technology landscape is no longer a niche for the select few. For Australian founders, it represents a monumental, yet frequently underestimated, investment opportunity. Fuelled by escalating geopolitical tensions and a fundamental re-prioritisation of global spending, this sector is experiencing an unprecedented tailwind. According to Steve Baxter, Lead Investor at Beaten Zone Venture […]
IPO Bound: The Strategic Edge Guiding Australian Investors to India’s Next Unicorns
Uncover Creek Partners’ strategic vision for Australian investors in India’s booming economy. From IPO-bound deals to pioneering tech exchange, this playbook reveals how to navigate and profit from a market set to hit $7 trillion.
Bridging the Gap: Why Australian Capital is Crucial for India’s Trillion-Dollar Growth Story
Australia’s substantial savings pool is meeting India’s explosive growth. Learn how Creek Partners is building the crucial bridge for investors seeking to tap into India’s projected $7 trillion economy and its vibrant venture capital ecosystem.
Backed By Leading Investment Groups and Family Offices
